Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are very similar because they have the same type of ...
Background: Small lymphocytic lymphoma is a relatively rare B-cell non-Hodgkin lymphoma that is considered to be the tissue equivalent of the much more common entity chronic lymphocytic leukemia.
The drug has been approved for relapsed/refractory (r/r) CLL/SLL, r/r marginal zone lymphoma and r/r mantle cell lymphoma on China's National Reimbursement Drug List. InnoCare Pharma focuses on ...
SUV remains the most widely used PET parameter to evaluate NHLs because it is directly associated with lymphoma aggressiveness.
This gap is especially significant in CLL / small lymphocytic lymphoma (SLL), the most common type of adult leukemia. 1,2 Biomarker testing, conducted through a blood test, provides critical insights ...
Beijing-based pharma, BeiGene’s Brukinsa (zanubrutinib) has been approved by the US Food and Drug Administration (FDA) for chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL ...
in combination with BTK inhibitor orelabrutinib as a first-line therapy for the treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) patients in China. ICP-248 ...
These are two closely related types of B-cell lymphoma. They grow slowly, starting in your blood and bone marrow (CLL) or spleen (SLL). It’s hard to cure these types of cancer. But because they ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback